A healthy pipeline and strong patent protection are vital to the success of pharmaceutical companies. Drug giant�Merck (NYSE:MRK), has faced both patent expirations and a weak pipeline in the past year. Still, the stock is up almost 10 percent in the last 12 months. Will Merck�� share price continue to rise in the second half of 2013? Let�� use our CHEAT SHEET investing framework to decide whether Merck is an OUTPERFORM, WAIT AND SEE, or STAY AWAY.
C = Catalysts for the Stock�� MovementInvestors and analysts have critizized the lack of attractive late-stage drugs in Merck’s pipeline. An acquisition of drug maker Schering-Plough in 2009 has drastically increased the amount of these late-stage drugs Merck has in its inventory. Schering-Plough also provides synergies to Merck�� business operations and will cut down on expenses in the coming years.
Merck suffered a blow on Wednesday as the Food and Drug Administration cancelled a meeting to determine the approval of reverse-anesthesia drug sugammadex. The surgery drug is already experiencing success overseas — marketed under the name Bridion — but with the FDA denying approval back in 2008, it has a long way to go before it can be sold in the U.S. This setback comes after the FDA denied approval for insomnia drug suvorexant earlier this month.
Hot Logistics Companies To Watch In Right Now: Fortress Investment Group LLC (FIG)
Fortress Investment Group LLC (Fortress) is a global investment management firm. Its offering of alternative investment products includes private equity funds, liquid hedge funds and credit funds. In addition, it offers traditional investment products. As of December 31, 2011, it managed alternative assets in three businesses: Private Equity, Liquid Hedge Funds and Credit Funds. Private Equity is a business, which manages assets under management (AUM) consisted of two business segments: private equity funds, which make investments in debt and equity securities of public or privately held entities in North America and Western Europe, and publicly traded alternative investment vehicles, which it refer to as Castles, which invest in real estate and real estate related debt investments. Liquid Hedge Funds invest globally in fixed income, currency, equity and commodity markets and related derivatives. Credit Funds is a business, which manages AUM consisted of two business segments: credit hedge funds which make investments in assets, opportunistic lending situations and securities, on a global basis and throughout the capital structure, as well as non-Fortress originated funds, for which Fortress has been retained as manager as part of an advisory business, and credit private equity (PE) funds, which are consisted of a family of credit opportunities funds focused on investing in distressed and undervalued assets, a range of long dated value funds focused on investing in undervalued assets with cash flows and long investment horizons, a range of real assets funds focused on investing in tangible and intangible assets in four principal categories (real estate, capital assets and natural resources), a family of Asia funds, including Japan real estate funds and an Asian investor based global opportunities fund, and a range of real estate opportunities funds.
Private Equity Funds
The Company�� private equity business is made up of a series of funds named the Fortress Investment Funds! and organized to make control-oriented investments in cash flow generating, asset-based businesses in North America and Western Europe. Investors in its private equity funds contractually commit capital at the outset of a fund, which is then drawn down as investment opportunities become available, generally over a one to three year investment period. Management fees of 1% to 1.5% are generally charged on committed capital during the investment period of a new fund, and then on invested capital (or net asset value (NAV), if lower). It also earns a 10% to 25% share of the profits on each realized investment in a fund.
The Company manages two companies: Newcastle Investment Corp. and Eurocastle Investment Limited, which it calls its Castles. It earns management fees from each Castle equal to 1.5% of the company�� equity. In addition, it earns incentive income equal to 25% of the company�� funds from operations (FFO) in excess of specified returns to the Company�� shareholders. In addition to these fees, it also receives from the Castles, for services provided, options to purchase shares of their common stock in connection with each of their common stock offerings.
Liquid Hedge Funds
The Fortress Macro Funds, and Fortress�� legacy macro-strategy funds, the Drawbridge Global Macro Funds, apply an investment process based on macroeconomic fundamental, market momentum and technical analyses. The funds have the flexibility to allocate capital dynamically across a range of global strategies, markets and instruments as opportunities change, and are designed to take advantage of a range of sources of market, economic and pricing data to generate trading ideas. The fund invests in developed markets; they also invest in emerging markets if market conditions present opportunities for attractive returns. The funds pursue global macro directional and relative value strategies. Management fees are charged based on the AUM of the Fortress Macro Funds at a rate between 1.5%! and 2% a! nnually, depending on the investment and liquidity terms elected by investors. It earns incentive income of between 15% and 25% of the fund�� profits, generally payable annually, depending on the investment and liquidity terms elected by investors. In other words, an incentive income payment establishes a high water mark, such that the fund must earn a cumulative positive return from that point forward in order for Fortress to earn incentive income. Investors in the Fortress Macro Funds may invest with the right to redeem without paying any redemption fee either monthly, quarterly, or annually after three years. Investors with three-year liquidity may redeem annually before three years, subject to an early redemption fee payable to the funds.
The Fortress Asia Macro Funds invest in global fixed income, commodities, currency and equity markets, and their related derivatives, thematically related to the Asia-Pacific region through a fundamental macroeconomic strategy, which focuses on liquid investments. The funds��investment program focuses on global trading and capital flows. Management fee rates for these funds range from 1.5% to 2% and it earns incentive income equal to 20% of their profits. Commodities Funds invests across multiple sectors within the commodity asset class ranging from energy to metals to agriculture and within the cyclical, industrial, and commodity equity universe. Management fee rates for these funds range from 1.5% to 2% and it earns incentive income equal to 20% of their profits. The Fortress Partners Fund�� investments are made both in Fortress Funds and in funds managed by other managers, and in direct investments that are sourced either by Fortress personnel or by third parties with whom it has relationships. Management fee rates for these funds range from 1% to 1.5% and it earns incentive income generally equal to 20% of the profits from direct investments only.
Credit Funds
The Company�� credit hedge funds are designed to exploi! t pricing! anomalies, which exist between the public and private finance markets. It has developed a network consisted of internal and external resources to source transactions for the funds. The funds are able to invest in a range of financial instruments, ranging from assets, opportunistic lending situations and securities throughout the capital structure with a value orientation.
The Drawbridge Special Opportunities Funds form the core of the Company�� credit hedge fund investing strategy. The funds acquire a portfolio of investments throughout the United States, Western Europe and the Pacific region. Management fees are charged based on the AUM of the Drawbridge Special Opportunities Funds at a rate generally equal to 2% annually. It earns incentive income of 20% of the fund�� profits, payable annually, and subject to achieving cumulative positive returns since the prior incentive income payment. Investors in the Drawbridge Special Opportunities Funds may redeem annually on December 31. The Worden Funds invest in a portfolio of undervalued and distressed investments in North America and Western Europe, but also in Australia, Asia and elsewhere on an opportunistic basis. Management fees are charged based on the AUM of the Worden Funds at a rate generally equal to 2% annually. It earns incentive income of 20% of the funds��profits.
The Company�� credit PE funds are of families of funds. They have management fee rates between 1% and 1.5% and generate incentive income of between 10% and 20% of a fund�� profits subject to the fund achieving a minimum return as a whole. Fortress through Fortress Credit Opportunities Funds make opportunistic credit-related investments. In addition to its Fortress Investment Fund family of funds, it has a private equity fund product, the Long Dated Value family of funds, which focuses on making investments with long dated cash flows. Its Real Assets Funds invest in tangible and intangible assets. The investment program of these funds focuses on di! rect inve! stments in four principal investment categories: real estate, capital assets and natural resources, but also may include indirect investments in the form of interests in real estate investment trusts (REITs), master limited partnerships, corporate securities, debt securities and debt obligations, including those that provide equity upside, as well as options, royalties, residuals and other call rights. The investments are located in North America and Western Europe. Fortress Japan Opportunity Funds focus to invest in Japanese real estate-related performing, sub-performing and non-performing loans, securities and similar instruments. Real Estate Opportunities Funds make opportunistic commercial real estate investments.
Advisors' Opinion:- [By Inyoung Hwang]
He currently has buy recommendations on private-equity firm Fortress Investment Group LLC (FIG) and Zions Bancorporation. (ZION)
Analysts SurveyedTo compile the ranking, Stamford, Connecticut-based Greenwich Associates surveyed 945 buy-side analysts at 190 investment management firms, mutual funds, hedge funds, pension funds and insurers from December to March. The analysts were asked to name the Wall Street research teams they considered their most important sources of advice on investments.
- [By Amanda Alix]
This turn of events worked in favor of Fortress Investment Group's (NYSE: FIG ) portfolio, which held the former Centex Corp, the subprime mortgage lending unit of a Texas homebuilder. That company is now Nationstar, which is definitely doing its fair share to add to its parent's bottom line. Also owned by Fortress is Newcastle Investment (NYSE: NCT ) , the diversified REIT with an involvement in almost anything to do with real estate, whether residential or commercial.
Top 5 Healthcare Technology Stocks To Watch For 2014: Massive Dynamics Inc (MSSD)
Massive Dynamics, Inc., incorporated on March 15, 2011, is a development-stage company. The Company is providing services to communication tower operators. On August 20, 2012, Kylemore Corp. (Kylemore) approximately 90% of the Company. On April 16, 2013, the Company entered into an Asset Purchase Agreement with Real-View 3D (RV3D). With the Company's acquisition of the assets of RV3D, the Company is providing engineering and compliance to communications tower operators to three dimension (3D) imaging. RV3D is an image capture product company that has developed and is committed to design, patent, manufacture and market 3D imaging Z-axis capture products for the consumer computer peripherals market.
The Company has developed technology around an imaging technology known as structured light, which allows for the rapid capture and processing of the digital signal capture 3D images of objects or real time 3D video of a desired target. A structured light image is a calibrated grid of lines that is projected on the subject. These projected lines deviate as they fall over the subject. An image of these lines is captured. Real View 3D software can extract Z-axis data from these line deviations and a topographical map is created. To image a complete subject, the subject is rotated 360 degrees for the image and then another 360 degree rotation for capturing the structured light for the Z axis map information. The resulting Z axis map and the image are then fused into a 360 degree renderable image. This image can then be exported into many other formats for viewing. The Company's primary business will be to develop and market 3D scanning, capture, rendering, and printing products to four markets: consumer, commercial, industrial, and medical.
Advisors' Opinion:- [By Rich Smith]
The problem with that, of course, is that competition is beginning to emerge in machine selling, as small companies with names such as ExOne (NASDAQ: XONE ) and Massive Dynamics (NASDAQOTH: MSSD ) begin to horn in on the printer biz. Competition will probably arise even faster in the selling of printing composites, as Hewlett-Packard discovered to its detriment, when printer ink cartridge "refillers" began stealing away its lucrative ink business.
Top 5 Healthcare Technology Stocks To Watch For 2014: E.I. du Pont de Nemours and Company(DD)
E. I. du Pont de Nemours and Company operates as a science and technology company worldwide. It operates in seven segments: Agriculture & Nutrition, Electronics & Communications, Performance Chemicals, Performance Coatings, Performance Materials, Safety & Protection, and Pharmaceuticals. The Agriculture & Nutrition segment provides hybrid seed corn and soybean seed, herbicides, fungicides, insecticides, value enhanced grains, and soy protein under the Pioneer brand name. The Electronics & Communications segment supplies materials and systems for photovoltaic products, consumer electronics, displays, and advanced printing. The Performance Chemicals segment offers fluorochemicals, fluoropolymers, specialty and industrial chemicals, and white pigments for various markets, such as plastics and coatings, textiles, mining, pulp and paper, water treatment, and healthcare. The Performance Coatings segment supplies high performance liquid and powder coatings for motor vehicle origi nal equipment manufacturers (OEM); the motor vehicle after-market; and general industrial applications, such as such as coatings for heavy equipment, pipes and appliances, and electrical insulation. The Performance Materials segment provides polymers, elastomers, films, parts, and systems and solutions for the automotive OEM and associated after-market industries, as well as electrical, electronics, packaging, construction, oil, photovoltaics, aerospace, chemical processing, and consumer durable goods. The Safety & Protection segment primarily offers nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The Pharmaceuticals segment represents its interest in the collaboration relating to Cozaar/Hyzaar antihypertensive drugs. The company was founded in 1802 and is headquartered in Wilmington, Dela ware.
Advisors' Opinion:- [By John Divine]
The S&P 500 Index (SNPINDEX: ^GSPC ) ended modestly higher on Friday, ending the week on a bullish note as the end of the second quarter approaches. Wall Street and Main Street alike are hoping that the second, third, and fourth quarters of 2014 will see higher growth than the first quarter, when the U.S. economy actually contracted at a 2.9% annualized rate. Dollar General (NYSE: DG ) , VeriSign (NASDAQ: VRSN ) , and DuPont (NYSE: DD ) investors weren't too optimistic about growth today, as those three stocks ended as the worst performers in the entire S&P index. The S&P, for its part, tacked on three points, or 0.2%, to end at 1,960.
- [By Dan Caplinger]
Driving the Dow higher are two industrial giants, United Technologies (NYSE: UTX ) and DuPont (NYSE: DD ) . For United Tech, a combination of continued strength in the aerospace industry and solid gains by its elevator segment sent the stock up 2.9%. The conglomerate also raised the lower end of its previous full-year earnings guidance, pointing to the success of its Goodrich acquisition in boosting sales of parts for large commercial engines. One analyst estimated that 65% of aircraft components now come from United Tech businesses, leaving its future firmly connected with currently rosy projections about aerospace demand over the next couple of decades.
- [By Matt Thalman]
Before we hit the Dow losers, let's look at the index's big winner of the week: DuPont (NYSE: DD ) , which ended the week higher by 7.54% after gaining 4.13% on Tuesday alone. The big move came as the result of DuPont's Q1 results, in which it matched expectations on revenue, beat estimates on earnings per share, and raised its dividend by 5%. The company also reaffirmed its 2013 full-year forecast, which is 2% to 7% higher than what DuPont posted in 2012. �
Top 5 Healthcare Technology Stocks To Watch For 2014: Cardiovascular Systems Inc.(CSII)
Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Diamondback 360�PAD System, the Diamondback Predator 360�PAD System, and Stealth 360�PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The PAD Systems consists of a single-use catheter that travels over its proprietary ViperWire guidewire and are used in conjunction with a reusable external control unit or a saline infusion pump. It markets and sells its products through direct sales force to hospitals and office based laboratories in the United States. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device company Cardiovascular Systems (NASDAQ: CSII ) has received a distressing two-star ranking.
- [By James Oberweis]
Cardiovascular Systems, Inc. (CSII) sells devices (called atherectomy devices) that remove the plaque altogether versus traditional angioplasty devices that push the plaque into the vessel.
- [By Todd Campbell]
So far I've outlined the reasons for the robust returns last year at diabetes device maker Dexcom and cardiovascular device play Cardiovascular Systems (NASDAQ: CSII ) . That brings us to No. 3 in my series,�Abiomed (NASDAQ: ABMD ) , a company that saw its latest product line propel its shares 98% higher in 2013.
No comments:
Post a Comment